Pipeline Program
Dermatological Disorders
Key Facts
About Hoth Therapeutics
Hoth Therapeutics is a publicly traded biopharma company with a patient-centric mission to develop innovative treatments that improve quality of life. Its core asset is the BioLexa Platform, a topical treatment for atopic dermatitis, and it is expanding its pipeline into oncology, neurology, and inflammatory dermatology. The company operates as a pre-revenue, clinical-stage entity focused on addressing significant unmet medical needs through targeted therapeutic approaches.
View full company profileAbout Hoth Therapeutics
Hoth Therapeutics is a publicly traded biopharma company with a patient-centric mission to develop innovative treatments that improve quality of life. Its core asset is the BioLexa Platform, a topical treatment for atopic dermatitis, and it is expanding its pipeline into oncology, neurology, and inflammatory dermatology. The company operates as a pre-revenue, clinical-stage entity focused on addressing significant unmet medical needs through targeted therapeutic approaches.
View full company profileAbout Hoth Therapeutics
Hoth Therapeutics is a publicly traded biopharma company with a patient-centric mission to develop innovative treatments that improve quality of life. Its core asset is the BioLexa Platform, a topical treatment for atopic dermatitis, and it is expanding its pipeline into oncology, neurology, and inflammatory dermatology. The company operates as a pre-revenue, clinical-stage entity focused on addressing significant unmet medical needs through targeted therapeutic approaches.
View full company profileAbout Hoth Therapeutics
Hoth Therapeutics is a publicly traded biopharma company with a patient-centric mission to develop innovative treatments that improve quality of life. Its core asset is the BioLexa Platform, a topical treatment for atopic dermatitis, and it is expanding its pipeline into oncology, neurology, and inflammatory dermatology. The company operates as a pre-revenue, clinical-stage entity focused on addressing significant unmet medical needs through targeted therapeutic approaches.
View full company profileAbout Hoth Therapeutics
Hoth Therapeutics is a publicly traded biopharma company with a patient-centric mission to develop innovative treatments that improve quality of life. Its core asset is the BioLexa Platform, a topical treatment for atopic dermatitis, and it is expanding its pipeline into oncology, neurology, and inflammatory dermatology. The company operates as a pre-revenue, clinical-stage entity focused on addressing significant unmet medical needs through targeted therapeutic approaches.
View full company profile